Insider Trends: ResMed Insider Extends 90-Day Selling Trend
07:09 PM EDT, 05/11/2021 (MT Newswires) -- Brett Sandercock, CFO, on May 10, 2021, sold 2,500 shares in ResMed (RMD) for $490,000. Subsequent to the Form 4 filing with the SEC, Sandercock has 92,502 shares of company stock, with a market value, based on the prior-day closing price, of $17.9 million.
In the 90 days prior to the date of this filing, there have been 13 transactions reported to the SEC, all of which have been sales and have resulted in the disposition of 24,304 company shares by insiders. This compares with the preceding 90-day window of time where there were 46 transactions from 14 insiders which resulted in the net acquisition of 129,051 shares.
This is lower than the average level of insider transactions in the 100-company Advanced Medical Equipment & Technology peer group over the last 90-day period. Within the peer group activity averaged 111.6 transactions per company, and disposition of 3,229 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/943819/000112760221016280/xslF345X03/form4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.